Medical Cannabis Pay Stock Current Asset
Fundamental analysis of Medical Cannabis allows traders to better anticipate movements in Medical Cannabis' stock price by examining its financial health and performance throughout various phases of its business cycle.
Medical |
Medical Cannabis Pay Company Current Asset Analysis
Medical Cannabis' Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Current Medical Cannabis Current Asset | 56 K |
Most of Medical Cannabis' fundamental indicators, such as Current Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medical Cannabis Pay is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.
CompetitionIn accordance with the recently published financial statements, Medical Cannabis Pay has a Current Asset of 56 K. This is 100.0% lower than that of the Healthcare sector and significantly higher than that of the Health Information Services industry. The current asset for all United States stocks is 100.0% higher than that of the company.
Medical Current Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medical Cannabis' direct or indirect competition against its Current Asset to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Medical Cannabis could also be used in its relative valuation, which is a method of valuing Medical Cannabis by comparing valuation metrics of similar companies.Medical Cannabis is currently under evaluation in current asset category among its peers.
Medical Fundamentals
| Return On Asset | -42.59 | |||
| Current Valuation | 4.53 M | |||
| Price To Earning | (10.30) X | |||
| EBITDA | (4.19 M) | |||
| Net Income | (4.25 M) | |||
| Cash And Equivalents | 27.7 K | |||
| Total Debt | 230.35 K | |||
| Current Ratio | 0.09 X | |||
| Book Value Per Share | (0) X | |||
| Cash Flow From Operations | (302.56 K) | |||
| Earnings Per Share | (0.01) X | |||
| Beta | 1.55 | |||
| Market Capitalization | 1.4 M | |||
| Total Asset | 52.7 K | |||
| Retained Earnings | (975 K) | |||
| Working Capital | (114 K) | |||
| Current Asset | 56 K | |||
| Current Liabilities | 170 K | |||
| Net Asset | 52.7 K |
Currently Active Assets on Macroaxis
| USOI | Credit Suisse X Links | |
| ULTY | Tidal Trust II | |
| CONY | YieldMax N Option | |
| BCAT | BlackRock Capital Allocation | |
| PDI | Pimco Dynamic Income |
Other Information on Investing in Medical Pink Sheet
Medical Cannabis financial ratios help investors to determine whether Medical Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medical with respect to the benefits of owning Medical Cannabis security.